C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2001
10/17/2001	EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001	EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001	EP1143995A1 Anti-dandruff composition comprising an antifungal polypeptide
10/17/2001	EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/17/2001	EP0873405A4 Expression augmenting sequence elements (ease) for eukaryotic expression systems
10/17/2001	EP0792367B1 A dna construct encoding the yap3 signal peptide
10/17/2001	EP0692025B1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
10/17/2001	EP0672120B1 Production of human monoclonal antibodies active against hepatitis b surface antigen
10/17/2001	EP0617706B1 Multivalent antigen-binding proteins
10/17/2001	EP0610474B1 Animal cell culture
10/17/2001	EP0489149B1 Probes for detecting mutant p53
10/17/2001	CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001	CN1318101A New human growth differentiation factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001	CN1318100A New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001	CN1318070A Modified i(E.coli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein
10/17/2001	CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
10/17/2001	CN1317976A Multicomponent vaccines
10/17/2001	CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1073159C Human kunitz-type protease inhibitors and its related method
10/17/2001	CN1073154C Superoxide dismutase-4
10/17/2001	CN1073118C Diagnostics virus of hepatitis C
10/17/2001	CN1073117C Antibiotic peptide and prodn. method and use thereof
10/17/2001	CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof
10/16/2001	US6303847 Nucleotide sequence; for transgenic plants
10/16/2001	US6303769 Lerk-5 dna
10/16/2001	US6303765 Polynucleotide which codes for protein of defined amino acids sequence; recombinant production; anticarcinogenic agents; antiarthritic agents; treatment of immune disorders such as multiple sclerosis and myasthenia gravis; diagnosis
10/16/2001	US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
10/16/2001	US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/16/2001	US6303751 Human metabotropic glutamate receptor and related DNA compounds
10/16/2001	US6303580 Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity
10/16/2001	US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis
10/16/2001	US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering
10/16/2001	US6303361 Human glandular kallikrein-1 (hK2)
10/16/2001	US6303360 Polypeptides having aminopeptidase activity and nucleic acids encoding same
10/16/2001	US6303358 Enzymatic polypeptide for use in the treatment of alzheimer's neuropathies, and diabetes
10/16/2001	US6303344 Methods and compositions for polypeptide engineering
10/16/2001	US6303341 Genetically engineered antibody for use in immunotherapy
10/16/2001	US6303337 Adding misaminoacylated initiator trna that recognizes only the first aug codon to translation system; gene expression, evaluation; genetic engineering
10/16/2001	US6303331 Vertebrate apoptosis gene: compositions and methods
10/16/2001	US6303324 Monitoring tumor propagation in humans; obtain tumor, determine nuclear pattern of tumor suppressor protein, determine pattern of thrombospondin in sample, compare to noncancerous tumor, determine vascularization of tumor
10/16/2001	US6303323 Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
10/16/2001	US6303320 Polypeptide of protein P140 and DNAs encoding it
10/16/2001	US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection
10/16/2001	US6303128 Method for protein expression
10/16/2001	US6303124 Compounds
10/16/2001	US6303121 Method of using human receptor protein 4-1BB
10/16/2001	US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
10/16/2001	CA2087969C Protease resistant pdgf and methods of use
10/16/2001	CA2044626C Type a platelet-derived growth factor receptor gene
10/16/2001	CA2036463C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
10/16/2001	CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
10/16/2001	CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants
10/16/2001	CA1341305C Dna binding proteins including androgen receptor
10/11/2001	WO2001075454A2 Diagnosis and treatment of alzheimer's disease
10/11/2001	WO2001075140A1 HYBRID CYTOKINE OF IL-7 AND β-CHAIN OF HEPATOCYTE GROWTH FACTOR
10/11/2001	WO2001075110A2 Mucin-1 specific binding members and methods of use thereof
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075095A1 Process for producing recombinant protein
10/11/2001	WO2001075082A1 DEOXYRIBONUCLEASE IIβ PROTEINS AND cDNAs
10/11/2001	WO2001075074A1 Novel proteins
10/11/2001	WO2001075067A2 Novel nucleic acids and polypeptides
10/11/2001	WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001	WO2001074884A1 Dermacentor variabilis gaba-gated chloride channels
10/11/2001	WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
10/11/2001	WO2001074838A1 Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus
10/11/2001	WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001032702A9 Molecular structure of rhd negative locus
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001027612A3 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001018038A3 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
10/11/2001	WO2001007625A3 Ehrlichia canis genes and vaccines
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2000063382A9 Genes and expression products from hematopoietic cells
10/11/2001	WO2000052135A9 Engineering intracellular sialylation pathways
10/11/2001	WO2000049413A9 Rapid assay for arthropod-borne disease vectors and pathogens
10/11/2001	WO2000026240A3 Streptococcal alpha2m-binding protein
10/11/2001	US20010029034 Hemostasis system-related disorders treatment
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof
10/11/2001	US20010029024 Selection of peptides with antibody-like properties
10/11/2001	US20010028883 Papillomavirus cellular receptor
10/11/2001	US20010028881 Determination concentrtaion
10/11/2001	DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides
10/11/2001	CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	CA2404567A1 Process for producing recombinant protein
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404479A1 Hybrid cytokine of il-7 and .beta.-chain of hepatocyte growth factor
10/11/2001	CA2403998A1 Mucin-1 specific binding members and methods of use thereof

1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 1125